COVID-19 special collection

PMID: 33075298

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.

Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, Hirayama AV, Mastroiani F, Turtle CJ, Harhay MO, Legrand M, Deutschman CS.

Lancet Respir Med. 2020 Dec;8(12):1233-1244. doi: 10.1016/S2213-2600(20)30404-5. Epub 2020 Oct 16.PMID: 33075298 Free PMC article.

PMID: 33264547

Cytokine Storm.

Fajgenbaum DC, June CH.

N Engl J Med. 2020 Dec 3;383(23):2255-2273. doi: 10.1056/NEJMra2026131.PMID: 33264547 

Free PMC article. Review. No abstract available.

PMID: 32425294

Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.

England JT, Abdulla A, Biggs CM, Lee AYY, Hay KA, Hoiland RL, Wellington CL, Sekhon M, Jamal S, Shojania K, Chen LYC.

Blood Rev. 2021 Jan;45:100707. doi: 10.1016/j.blre.2020.100707. Epub 2020 May 15.PMID: 32425294 Free PMC article. Review.

Preliminary predictive criteria for COVID-19 cytokine storm.

Caricchio R, Gallucci M, Dass C, Zhang X, Gallucci S, Fleece D, Bromberg M, Criner GJ; Temple University COVID-19 Research Group.

Ann Rheum Dis. 2021 Jan;80(1):88-95. doi: 10.1136/annrheumdis-2020-218323. Epub 2020 Sep 25.PMID: 32978237 Review.

PMID: 32896310

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.

Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA.

J Allergy Clin Immunol. 2020 Sep;146(3):518-534.e1. doi: 10.1016/j.jaci.2020.07.001.PMID: 32896310 Free PMC article. Review.

PMID: 33007328

Highways to hell: Mechanism-based management of cytokine storm syndromes.

Canna SW, Cron RQ.

J Allergy Clin Immunol. 2020 Nov;146(5):949-959. doi: 10.1016/j.jaci.2020.09.016. Epub 2020 Sep 29.PMID: 33007328 Free PMC article. Review.

PMID: 33214057

A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.

Lu L, Zhang H, Dauphars DJ, He YW.

Trends Immunol. 2021 Jan;42(1):3-5. doi: 10.1016/j.it.2020.10.012. Epub 2020 Nov 2.PMID: 33214057 Free PMC article. Review.

PMID: 33153908

Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.

Lee S, Channappanavar R, Kanneganti TD.

Trends Immunol. 2020 Dec;41(12):1083-1099. doi: 10.1016/j.it.2020.10.005. Epub 2020 Oct 15.PMID: 33153908 Free PMC article. Review.

PMID: 33051104

A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.

Cabler SS, French AR, Orvedahl A.

Trends Mol Med. 2020 Dec;26(12):1078-1085. doi: 10.1016/j.molmed.2020.09.012. Epub 2020 Sep 30.PMID: 33051104 Free PMC article. Review.

PMID: 33391477

Immunopathogenesis and treatment of cytokine storm in COVID-19.

Kim JS, Lee JY, Yang JW, Lee KH, Effenberger M, Szpirt W, Kronbichler A, Shin JI.

Theranostics. 2021 Jan 1;11(1):316-329. doi: 10.7150/thno.49713. eCollection 2021.PMID: 33391477 Free PMC article. Review.

PMID: 32929876

The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.

Chau AS, Weber AG, Maria NI, Narain S, Liu A, Hajizadeh N, Malhotra P, Bloom O, Marder G, Kaplan B.

Arthritis Rheumatol. 2021 Jan;73(1):23-35. doi: 10.1002/art.41526. Epub 2020 Dec 1.PMID: 32929876 Review.

PMID: 32291137

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Liu B, Li M, Zhou Z, Guan X, Xiang Y.

J Autoimmun. 2020 Jul;111:102452. doi: 10.1016/j.jaut.2020.102452. Epub 2020 Apr 10.PMID: 32291137 Free PMC article. Review.

PMID: 32961074

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.

Fara A, Mitrev Z, Rosalia RA, Assas BM.

Open Biol. 2020 Sep;10(9):200160. doi: 10.1098/rsob.200160. Epub 2020 Sep 23.PMID: 32961074 Free PMC article. Review.

PMID: 33072097

COVID-19: In the Eye of the Cytokine Storm.

de la Rica R, Borges M, Gonzalez-Freire M.

Front Immunol. 2020 Sep 24;11:558898. doi: 10.3389/fimmu.2020.558898. eCollection 2020.PMID: 33072097 Free PMC article. Review.

PMID: 33621130

Perspectives on Targeting IL-6 as a Potential Therapeutic Strategy for COVID-19.

Khaedir Y, Kartika R.

J Interferon Cytokine Res. 2021 Feb;41(2):37-43. doi: 10.1089/jir.2020.0135.PMID: 33621130 Review.

PMID: 33113222

T cell immunobiology and cytokine storm of COVID-19.

Luo XH, Zhu Y, Mao J, Du RC.

Scand J Immunol. 2021 Mar;93(3):e12989. doi: 10.1111/sji.12989. Epub 2020 Nov 25.PMID: 33113222 Free PMC article. Review.

PMID: 32794180

IL-18 and infections: Is there a role for targeted therapies?

Vecchié A, Bonaventura A, Toldo S, Dagna L, Dinarello CA, Abbate A.

J Cell Physiol. 2021 Mar;236(3):1638-1657. doi: 10.1002/jcp.30008. Epub 2020 Aug 13.PMID: 32794180 Review.

PMID: 33850327 

Is IL-6 a key cytokine target for therapy in COVID-19?

Jones SA, Hunter CA. Nat Rev Immunol. 2021 Apr 13:1-3. doi: 10.1038/s41577-021-00553-8. Online ahead of print.